Derek McLister
Podiatrist · Fargo, NDNPI 1114453552
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (30.4%), speaking fees and education — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Arthrex at 52.0% of the total. Reporting peaked in 2022 at $10,421 and has fallen 85.7% since, to $1,491 in 2025.
Across 267 payments — averaging $172.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$24K
- Sioux Surgical Inc$10K
- Stryker$5K
- Smith+Nephew$2K
- Paragon 28, Inc.$1K
- Johnson & Johnson$1K
- plus $2K from 13 others
What the payments were for
- Speaking & faculty fees$11,75026%
- Travel & lodging$8,83819%
- Food & beverage$13,99230%
- Education$11,44725%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 68 | $23,952 |
| Sioux Surgical Inc | 65 | $10,170 |
| Stryker | 64 | $5,295 |
| Smith+Nephew | 24 | $1,819 |
| Paragon 28, Inc. | 3 | $1,390 |
| Johnson & Johnson | 21 | $1,385 |
| RSW Medical Company, Inc. | 4 | $597 |
| Ossio Inc | 2 | $555 |
| Kerecis Limited | 4 | $246 |
| Trilliant Surgical LLC. | 2 | $240 |
| International Life Sciences | 1 | $110 |
| Voom Medical Devices, Inc. | 1 | $93 |
| Oxford Performance Materials, Inc. | 1 | $42 |
| Organogenesis Inc. | 2 | $34 |
| Nevro Corp. | 1 | $25 |
| Next Science LLC | 1 | $22 |
| Avita Medical Americas, LLC | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Polynovo North America LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PRIME SERIES$845
- PROPHECY$782
- INFINITY$690
- Kerecis Omega3 Marigen$588
- TAR$561
- STRAVIX MESH$525
- VARIAX$458
- ORTHOLOC 3DI$298
- NA$286
- INFINITY ADAPTIS$175
- PROstep$171
- AUGMENT INJECTABLE$165
- MOTOBAND$150
- FIBERGRAFT Aeridyan Matrix$150
- Kerecis Omega3 SurgiClose$147
- Fibulink$146
- Arsenal Ankle 10 Hole 1/3 Tubular Plate$143
- STRAVIX PL$127
- Stravix$123
- DART-FIRE$121
How this compares
Too few podiatrist providers in North Dakotato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 94 | $259 |
| Ibuprofen | 51 | $252 |
| Diclofenac Sodium | 14 | $152 |
| Ondansetron Hcl | 56 | $115 |
| Hydromorphone Hcl | 19 | $75 |
| Tramadol Hcl | 11 | $17 |
| Meloxicam | 11 | $4 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Fargo
- Travis FitzkeFargo$9K
- Ryan JamesonFargo$7K
- Mark DomaasFargo$4K
- Lee HofsommerFargo$843
- Paul ShearerFargo$7
- Tyson WilliamsMinot$10K
- Kayla EmterBismarck$9K
- Qianlin LiGrand Forks$8K
- Matthew KammererWahpeton$485
- Alisha JohnstonDevils Lake$338
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.